Sessions

Education Program

• Welcome and Opening Remarks (Day 1)
• How I Treat Hodgkin Lymphoma
• How I Treat Follicular Lymphoma
• How I Treat Mantle Cell Lymphoma
• Lymphoma Panel Discussion I
• How I Treat Low Grade MDS
• How I Treat High Grade MDS
• MDS Panel Discussion
• How I Treat Myelofibrosis Patients Who Have “Failed” Ruxolitinib
• How I Treat High-Risk Patients with Essential Thrombocythemia or Polycythemia Vera
• How I Treat MPN or CML: Who and When Am I Transplanting?
• MPN Panel Discussion
• How I Treat CLL
• How I Treat CLL: High-Risk Genetics
• CLL Panel Discussion
• Welcome and Opening Remarks
• How I Treat Hypocellular MDS
• How I Treat Relapsed AML: Do Molecular Genetics Help?
• MDS/AML Panel Discussion
• How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions
• How I Treat ALL in Older Adults: Ph+ and Ph- ALL
• ALL Panel Discussion
• How I Treat Diffuse Large B-Cell and Mediastinal Large Cell Lymphomas
• How I Treat Highly Aggressive Lymphomas: Burkitt, Double-Hit, B-Cell, and Unclassifiable with Features Intermediate between DLBCL and Burkitt Lymphoma
• Lymphoma Panel Discussion II
• How I Treat Myeloma Using Genomic Analysis
• How I Treat Newly Diagnosed Multiple Myeloma
• How I Treat Relapsed/Refractory Myeloma Including Novel Agents
• Myeloma Panel Discussion
• Closing Remarks and Adjournment